Global Short Bowel Syndrome Market Research Report 2024(Status and Outlook)
Report Overview:
Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition.
The Global Short Bowel Syndrome Market Size was estimated at USD 526.69 million in 2023 and is projected to reach USD 1364.96 million by 2029, exhibiting a CAGR of 17.20% during the forecast period.
This report provides a deep insight into the global Short Bowel Syndrome market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Short Bowel Syndrome Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Short Bowel Syndrome market in any manner.
Global Short Bowel Syndrome Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda
Merck
Emmaus Life Sciences
Nutrinia
GlyPharma Therapeutics
OxThera
Ardelyx
Sancilio & Company
Naia Pharmaceuticals
Zealand Pharma
Market Segmentation (by Type)
GLP-2
Growth Hormone
Glutamine
Others
Market Segmentation (by Application)
Hospitals
Clinics
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Short Bowel Syndrome Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition.
The Global Short Bowel Syndrome Market Size was estimated at USD 526.69 million in 2023 and is projected to reach USD 1364.96 million by 2029, exhibiting a CAGR of 17.20% during the forecast period.
This report provides a deep insight into the global Short Bowel Syndrome market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Short Bowel Syndrome Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Short Bowel Syndrome market in any manner.
Global Short Bowel Syndrome Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda
Merck
Emmaus Life Sciences
Nutrinia
GlyPharma Therapeutics
OxThera
Ardelyx
Sancilio & Company
Naia Pharmaceuticals
Zealand Pharma
Market Segmentation (by Type)
GLP-2
Growth Hormone
Glutamine
Others
Market Segmentation (by Application)
Hospitals
Clinics
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Short Bowel Syndrome Market
- Overview of the regional outlook of the Short Bowel Syndrome Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Short Bowel Syndrome Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Short Bowel Syndrome
1.2 Key Market Segments
1.2.1 Short Bowel Syndrome Segment by Type
1.2.2 Short Bowel Syndrome Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SHORT BOWEL SYNDROME MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Short Bowel Syndrome Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Short Bowel Syndrome Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SHORT BOWEL SYNDROME MARKET COMPETITIVE LANDSCAPE
3.1 Global Short Bowel Syndrome Sales by Manufacturers (2019-2024)
3.2 Global Short Bowel Syndrome Revenue Market Share by Manufacturers (2019-2024)
3.3 Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Short Bowel Syndrome Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Short Bowel Syndrome Sales Sites, Area Served, Product Type
3.6 Short Bowel Syndrome Market Competitive Situation and Trends
3.6.1 Short Bowel Syndrome Market Concentration Rate
3.6.2 Global 5 and 10 Largest Short Bowel Syndrome Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 SHORT BOWEL SYNDROME INDUSTRY CHAIN ANALYSIS
4.1 Short Bowel Syndrome Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SHORT BOWEL SYNDROME MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 SHORT BOWEL SYNDROME MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Short Bowel Syndrome Sales Market Share by Type (2019-2024)
6.3 Global Short Bowel Syndrome Market Size Market Share by Type (2019-2024)
6.4 Global Short Bowel Syndrome Price by Type (2019-2024)
7 SHORT BOWEL SYNDROME MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Short Bowel Syndrome Market Sales by Application (2019-2024)
7.3 Global Short Bowel Syndrome Market Size (M USD) by Application (2019-2024)
7.4 Global Short Bowel Syndrome Sales Growth Rate by Application (2019-2024)
8 SHORT BOWEL SYNDROME MARKET SEGMENTATION BY REGION
8.1 Global Short Bowel Syndrome Sales by Region
8.1.1 Global Short Bowel Syndrome Sales by Region
8.1.2 Global Short Bowel Syndrome Sales Market Share by Region
8.2 North America
8.2.1 North America Short Bowel Syndrome Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Short Bowel Syndrome Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Short Bowel Syndrome Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Short Bowel Syndrome Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Short Bowel Syndrome Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Takeda
9.1.1 Takeda Short Bowel Syndrome Basic Information
9.1.2 Takeda Short Bowel Syndrome Product Overview
9.1.3 Takeda Short Bowel Syndrome Product Market Performance
9.1.4 Takeda Business Overview
9.1.5 Takeda Short Bowel Syndrome SWOT Analysis
9.1.6 Takeda Recent Developments
9.2 Merck
9.2.1 Merck Short Bowel Syndrome Basic Information
9.2.2 Merck Short Bowel Syndrome Product Overview
9.2.3 Merck Short Bowel Syndrome Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Short Bowel Syndrome SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Emmaus Life Sciences
9.3.1 Emmaus Life Sciences Short Bowel Syndrome Basic Information
9.3.2 Emmaus Life Sciences Short Bowel Syndrome Product Overview
9.3.3 Emmaus Life Sciences Short Bowel Syndrome Product Market Performance
9.3.4 Emmaus Life Sciences Short Bowel Syndrome SWOT Analysis
9.3.5 Emmaus Life Sciences Business Overview
9.3.6 Emmaus Life Sciences Recent Developments
9.4 Nutrinia
9.4.1 Nutrinia Short Bowel Syndrome Basic Information
9.4.2 Nutrinia Short Bowel Syndrome Product Overview
9.4.3 Nutrinia Short Bowel Syndrome Product Market Performance
9.4.4 Nutrinia Business Overview
9.4.5 Nutrinia Recent Developments
9.5 GlyPharma Therapeutics
9.5.1 GlyPharma Therapeutics Short Bowel Syndrome Basic Information
9.5.2 GlyPharma Therapeutics Short Bowel Syndrome Product Overview
9.5.3 GlyPharma Therapeutics Short Bowel Syndrome Product Market Performance
9.5.4 GlyPharma Therapeutics Business Overview
9.5.5 GlyPharma Therapeutics Recent Developments
9.6 OxThera
9.6.1 OxThera Short Bowel Syndrome Basic Information
9.6.2 OxThera Short Bowel Syndrome Product Overview
9.6.3 OxThera Short Bowel Syndrome Product Market Performance
9.6.4 OxThera Business Overview
9.6.5 OxThera Recent Developments
9.7 Ardelyx
9.7.1 Ardelyx Short Bowel Syndrome Basic Information
9.7.2 Ardelyx Short Bowel Syndrome Product Overview
9.7.3 Ardelyx Short Bowel Syndrome Product Market Performance
9.7.4 Ardelyx Business Overview
9.7.5 Ardelyx Recent Developments
9.8 Sancilio and Company
9.8.1 Sancilio and Company Short Bowel Syndrome Basic Information
9.8.2 Sancilio and Company Short Bowel Syndrome Product Overview
9.8.3 Sancilio and Company Short Bowel Syndrome Product Market Performance
9.8.4 Sancilio and Company Business Overview
9.8.5 Sancilio and Company Recent Developments
9.9 Naia Pharmaceuticals
9.9.1 Naia Pharmaceuticals Short Bowel Syndrome Basic Information
9.9.2 Naia Pharmaceuticals Short Bowel Syndrome Product Overview
9.9.3 Naia Pharmaceuticals Short Bowel Syndrome Product Market Performance
9.9.4 Naia Pharmaceuticals Business Overview
9.9.5 Naia Pharmaceuticals Recent Developments
9.10 Zealand Pharma
9.10.1 Zealand Pharma Short Bowel Syndrome Basic Information
9.10.2 Zealand Pharma Short Bowel Syndrome Product Overview
9.10.3 Zealand Pharma Short Bowel Syndrome Product Market Performance
9.10.4 Zealand Pharma Business Overview
9.10.5 Zealand Pharma Recent Developments
10 SHORT BOWEL SYNDROME MARKET FORECAST BY REGION
10.1 Global Short Bowel Syndrome Market Size Forecast
10.2 Global Short Bowel Syndrome Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Short Bowel Syndrome Market Size Forecast by Country
10.2.3 Asia Pacific Short Bowel Syndrome Market Size Forecast by Region
10.2.4 South America Short Bowel Syndrome Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Short Bowel Syndrome by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Short Bowel Syndrome Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Short Bowel Syndrome by Type (2025-2030)
11.1.2 Global Short Bowel Syndrome Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Short Bowel Syndrome by Type (2025-2030)
11.2 Global Short Bowel Syndrome Market Forecast by Application (2025-2030)
11.2.1 Global Short Bowel Syndrome Sales (K Units) Forecast by Application
11.2.2 Global Short Bowel Syndrome Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Short Bowel Syndrome
1.2 Key Market Segments
1.2.1 Short Bowel Syndrome Segment by Type
1.2.2 Short Bowel Syndrome Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SHORT BOWEL SYNDROME MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Short Bowel Syndrome Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Short Bowel Syndrome Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SHORT BOWEL SYNDROME MARKET COMPETITIVE LANDSCAPE
3.1 Global Short Bowel Syndrome Sales by Manufacturers (2019-2024)
3.2 Global Short Bowel Syndrome Revenue Market Share by Manufacturers (2019-2024)
3.3 Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Short Bowel Syndrome Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Short Bowel Syndrome Sales Sites, Area Served, Product Type
3.6 Short Bowel Syndrome Market Competitive Situation and Trends
3.6.1 Short Bowel Syndrome Market Concentration Rate
3.6.2 Global 5 and 10 Largest Short Bowel Syndrome Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 SHORT BOWEL SYNDROME INDUSTRY CHAIN ANALYSIS
4.1 Short Bowel Syndrome Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SHORT BOWEL SYNDROME MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 SHORT BOWEL SYNDROME MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Short Bowel Syndrome Sales Market Share by Type (2019-2024)
6.3 Global Short Bowel Syndrome Market Size Market Share by Type (2019-2024)
6.4 Global Short Bowel Syndrome Price by Type (2019-2024)
7 SHORT BOWEL SYNDROME MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Short Bowel Syndrome Market Sales by Application (2019-2024)
7.3 Global Short Bowel Syndrome Market Size (M USD) by Application (2019-2024)
7.4 Global Short Bowel Syndrome Sales Growth Rate by Application (2019-2024)
8 SHORT BOWEL SYNDROME MARKET SEGMENTATION BY REGION
8.1 Global Short Bowel Syndrome Sales by Region
8.1.1 Global Short Bowel Syndrome Sales by Region
8.1.2 Global Short Bowel Syndrome Sales Market Share by Region
8.2 North America
8.2.1 North America Short Bowel Syndrome Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Short Bowel Syndrome Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Short Bowel Syndrome Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Short Bowel Syndrome Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Short Bowel Syndrome Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Takeda
9.1.1 Takeda Short Bowel Syndrome Basic Information
9.1.2 Takeda Short Bowel Syndrome Product Overview
9.1.3 Takeda Short Bowel Syndrome Product Market Performance
9.1.4 Takeda Business Overview
9.1.5 Takeda Short Bowel Syndrome SWOT Analysis
9.1.6 Takeda Recent Developments
9.2 Merck
9.2.1 Merck Short Bowel Syndrome Basic Information
9.2.2 Merck Short Bowel Syndrome Product Overview
9.2.3 Merck Short Bowel Syndrome Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Short Bowel Syndrome SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Emmaus Life Sciences
9.3.1 Emmaus Life Sciences Short Bowel Syndrome Basic Information
9.3.2 Emmaus Life Sciences Short Bowel Syndrome Product Overview
9.3.3 Emmaus Life Sciences Short Bowel Syndrome Product Market Performance
9.3.4 Emmaus Life Sciences Short Bowel Syndrome SWOT Analysis
9.3.5 Emmaus Life Sciences Business Overview
9.3.6 Emmaus Life Sciences Recent Developments
9.4 Nutrinia
9.4.1 Nutrinia Short Bowel Syndrome Basic Information
9.4.2 Nutrinia Short Bowel Syndrome Product Overview
9.4.3 Nutrinia Short Bowel Syndrome Product Market Performance
9.4.4 Nutrinia Business Overview
9.4.5 Nutrinia Recent Developments
9.5 GlyPharma Therapeutics
9.5.1 GlyPharma Therapeutics Short Bowel Syndrome Basic Information
9.5.2 GlyPharma Therapeutics Short Bowel Syndrome Product Overview
9.5.3 GlyPharma Therapeutics Short Bowel Syndrome Product Market Performance
9.5.4 GlyPharma Therapeutics Business Overview
9.5.5 GlyPharma Therapeutics Recent Developments
9.6 OxThera
9.6.1 OxThera Short Bowel Syndrome Basic Information
9.6.2 OxThera Short Bowel Syndrome Product Overview
9.6.3 OxThera Short Bowel Syndrome Product Market Performance
9.6.4 OxThera Business Overview
9.6.5 OxThera Recent Developments
9.7 Ardelyx
9.7.1 Ardelyx Short Bowel Syndrome Basic Information
9.7.2 Ardelyx Short Bowel Syndrome Product Overview
9.7.3 Ardelyx Short Bowel Syndrome Product Market Performance
9.7.4 Ardelyx Business Overview
9.7.5 Ardelyx Recent Developments
9.8 Sancilio and Company
9.8.1 Sancilio and Company Short Bowel Syndrome Basic Information
9.8.2 Sancilio and Company Short Bowel Syndrome Product Overview
9.8.3 Sancilio and Company Short Bowel Syndrome Product Market Performance
9.8.4 Sancilio and Company Business Overview
9.8.5 Sancilio and Company Recent Developments
9.9 Naia Pharmaceuticals
9.9.1 Naia Pharmaceuticals Short Bowel Syndrome Basic Information
9.9.2 Naia Pharmaceuticals Short Bowel Syndrome Product Overview
9.9.3 Naia Pharmaceuticals Short Bowel Syndrome Product Market Performance
9.9.4 Naia Pharmaceuticals Business Overview
9.9.5 Naia Pharmaceuticals Recent Developments
9.10 Zealand Pharma
9.10.1 Zealand Pharma Short Bowel Syndrome Basic Information
9.10.2 Zealand Pharma Short Bowel Syndrome Product Overview
9.10.3 Zealand Pharma Short Bowel Syndrome Product Market Performance
9.10.4 Zealand Pharma Business Overview
9.10.5 Zealand Pharma Recent Developments
10 SHORT BOWEL SYNDROME MARKET FORECAST BY REGION
10.1 Global Short Bowel Syndrome Market Size Forecast
10.2 Global Short Bowel Syndrome Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Short Bowel Syndrome Market Size Forecast by Country
10.2.3 Asia Pacific Short Bowel Syndrome Market Size Forecast by Region
10.2.4 South America Short Bowel Syndrome Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Short Bowel Syndrome by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Short Bowel Syndrome Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Short Bowel Syndrome by Type (2025-2030)
11.1.2 Global Short Bowel Syndrome Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Short Bowel Syndrome by Type (2025-2030)
11.2 Global Short Bowel Syndrome Market Forecast by Application (2025-2030)
11.2.1 Global Short Bowel Syndrome Sales (K Units) Forecast by Application
11.2.2 Global Short Bowel Syndrome Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Short Bowel Syndrome Market Size Comparison by Region (M USD)
Table 5. Global Short Bowel Syndrome Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Short Bowel Syndrome Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Short Bowel Syndrome Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Short Bowel Syndrome Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome as of 2022)
Table 10. Global Market Short Bowel Syndrome Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Short Bowel Syndrome Sales Sites and Area Served
Table 12. Manufacturers Short Bowel Syndrome Product Type
Table 13. Global Short Bowel Syndrome Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Short Bowel Syndrome
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Short Bowel Syndrome Market Challenges
Table 22. Global Short Bowel Syndrome Sales by Type (K Units)
Table 23. Global Short Bowel Syndrome Market Size by Type (M USD)
Table 24. Global Short Bowel Syndrome Sales (K Units) by Type (2019-2024)
Table 25. Global Short Bowel Syndrome Sales Market Share by Type (2019-2024)
Table 26. Global Short Bowel Syndrome Market Size (M USD) by Type (2019-2024)
Table 27. Global Short Bowel Syndrome Market Size Share by Type (2019-2024)
Table 28. Global Short Bowel Syndrome Price (USD/Unit) by Type (2019-2024)
Table 29. Global Short Bowel Syndrome Sales (K Units) by Application
Table 30. Global Short Bowel Syndrome Market Size by Application
Table 31. Global Short Bowel Syndrome Sales by Application (2019-2024) & (K Units)
Table 32. Global Short Bowel Syndrome Sales Market Share by Application (2019-2024)
Table 33. Global Short Bowel Syndrome Sales by Application (2019-2024) & (M USD)
Table 34. Global Short Bowel Syndrome Market Share by Application (2019-2024)
Table 35. Global Short Bowel Syndrome Sales Growth Rate by Application (2019-2024)
Table 36. Global Short Bowel Syndrome Sales by Region (2019-2024) & (K Units)
Table 37. Global Short Bowel Syndrome Sales Market Share by Region (2019-2024)
Table 38. North America Short Bowel Syndrome Sales by Country (2019-2024) & (K Units)
Table 39. Europe Short Bowel Syndrome Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Short Bowel Syndrome Sales by Region (2019-2024) & (K Units)
Table 41. South America Short Bowel Syndrome Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Short Bowel Syndrome Sales by Region (2019-2024) & (K Units)
Table 43. Takeda Short Bowel Syndrome Basic Information
Table 44. Takeda Short Bowel Syndrome Product Overview
Table 45. Takeda Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Takeda Business Overview
Table 47. Takeda Short Bowel Syndrome SWOT Analysis
Table 48. Takeda Recent Developments
Table 49. Merck Short Bowel Syndrome Basic Information
Table 50. Merck Short Bowel Syndrome Product Overview
Table 51. Merck Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Short Bowel Syndrome SWOT Analysis
Table 54. Merck Recent Developments
Table 55. Emmaus Life Sciences Short Bowel Syndrome Basic Information
Table 56. Emmaus Life Sciences Short Bowel Syndrome Product Overview
Table 57. Emmaus Life Sciences Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Emmaus Life Sciences Short Bowel Syndrome SWOT Analysis
Table 59. Emmaus Life Sciences Business Overview
Table 60. Emmaus Life Sciences Recent Developments
Table 61. Nutrinia Short Bowel Syndrome Basic Information
Table 62. Nutrinia Short Bowel Syndrome Product Overview
Table 63. Nutrinia Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Nutrinia Business Overview
Table 65. Nutrinia Recent Developments
Table 66. GlyPharma Therapeutics Short Bowel Syndrome Basic Information
Table 67. GlyPharma Therapeutics Short Bowel Syndrome Product Overview
Table 68. GlyPharma Therapeutics Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. GlyPharma Therapeutics Business Overview
Table 70. GlyPharma Therapeutics Recent Developments
Table 71. OxThera Short Bowel Syndrome Basic Information
Table 72. OxThera Short Bowel Syndrome Product Overview
Table 73. OxThera Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. OxThera Business Overview
Table 75. OxThera Recent Developments
Table 76. Ardelyx Short Bowel Syndrome Basic Information
Table 77. Ardelyx Short Bowel Syndrome Product Overview
Table 78. Ardelyx Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Ardelyx Business Overview
Table 80. Ardelyx Recent Developments
Table 81. Sancilio and Company Short Bowel Syndrome Basic Information
Table 82. Sancilio and Company Short Bowel Syndrome Product Overview
Table 83. Sancilio and Company Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Sancilio and Company Business Overview
Table 85. Sancilio and Company Recent Developments
Table 86. Naia Pharmaceuticals Short Bowel Syndrome Basic Information
Table 87. Naia Pharmaceuticals Short Bowel Syndrome Product Overview
Table 88. Naia Pharmaceuticals Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Naia Pharmaceuticals Business Overview
Table 90. Naia Pharmaceuticals Recent Developments
Table 91. Zealand Pharma Short Bowel Syndrome Basic Information
Table 92. Zealand Pharma Short Bowel Syndrome Product Overview
Table 93. Zealand Pharma Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Zealand Pharma Business Overview
Table 95. Zealand Pharma Recent Developments
Table 96. Global Short Bowel Syndrome Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Short Bowel Syndrome Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Short Bowel Syndrome Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Short Bowel Syndrome Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Short Bowel Syndrome Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Short Bowel Syndrome Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Short Bowel Syndrome Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Short Bowel Syndrome Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Short Bowel Syndrome Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Short Bowel Syndrome Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Short Bowel Syndrome Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Short Bowel Syndrome Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Short Bowel Syndrome Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Short Bowel Syndrome Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Short Bowel Syndrome Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Short Bowel Syndrome Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Short Bowel Syndrome Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Short Bowel Syndrome Market Size Comparison by Region (M USD)
Table 5. Global Short Bowel Syndrome Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Short Bowel Syndrome Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Short Bowel Syndrome Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Short Bowel Syndrome Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome as of 2022)
Table 10. Global Market Short Bowel Syndrome Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Short Bowel Syndrome Sales Sites and Area Served
Table 12. Manufacturers Short Bowel Syndrome Product Type
Table 13. Global Short Bowel Syndrome Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Short Bowel Syndrome
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Short Bowel Syndrome Market Challenges
Table 22. Global Short Bowel Syndrome Sales by Type (K Units)
Table 23. Global Short Bowel Syndrome Market Size by Type (M USD)
Table 24. Global Short Bowel Syndrome Sales (K Units) by Type (2019-2024)
Table 25. Global Short Bowel Syndrome Sales Market Share by Type (2019-2024)
Table 26. Global Short Bowel Syndrome Market Size (M USD) by Type (2019-2024)
Table 27. Global Short Bowel Syndrome Market Size Share by Type (2019-2024)
Table 28. Global Short Bowel Syndrome Price (USD/Unit) by Type (2019-2024)
Table 29. Global Short Bowel Syndrome Sales (K Units) by Application
Table 30. Global Short Bowel Syndrome Market Size by Application
Table 31. Global Short Bowel Syndrome Sales by Application (2019-2024) & (K Units)
Table 32. Global Short Bowel Syndrome Sales Market Share by Application (2019-2024)
Table 33. Global Short Bowel Syndrome Sales by Application (2019-2024) & (M USD)
Table 34. Global Short Bowel Syndrome Market Share by Application (2019-2024)
Table 35. Global Short Bowel Syndrome Sales Growth Rate by Application (2019-2024)
Table 36. Global Short Bowel Syndrome Sales by Region (2019-2024) & (K Units)
Table 37. Global Short Bowel Syndrome Sales Market Share by Region (2019-2024)
Table 38. North America Short Bowel Syndrome Sales by Country (2019-2024) & (K Units)
Table 39. Europe Short Bowel Syndrome Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Short Bowel Syndrome Sales by Region (2019-2024) & (K Units)
Table 41. South America Short Bowel Syndrome Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Short Bowel Syndrome Sales by Region (2019-2024) & (K Units)
Table 43. Takeda Short Bowel Syndrome Basic Information
Table 44. Takeda Short Bowel Syndrome Product Overview
Table 45. Takeda Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Takeda Business Overview
Table 47. Takeda Short Bowel Syndrome SWOT Analysis
Table 48. Takeda Recent Developments
Table 49. Merck Short Bowel Syndrome Basic Information
Table 50. Merck Short Bowel Syndrome Product Overview
Table 51. Merck Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Short Bowel Syndrome SWOT Analysis
Table 54. Merck Recent Developments
Table 55. Emmaus Life Sciences Short Bowel Syndrome Basic Information
Table 56. Emmaus Life Sciences Short Bowel Syndrome Product Overview
Table 57. Emmaus Life Sciences Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Emmaus Life Sciences Short Bowel Syndrome SWOT Analysis
Table 59. Emmaus Life Sciences Business Overview
Table 60. Emmaus Life Sciences Recent Developments
Table 61. Nutrinia Short Bowel Syndrome Basic Information
Table 62. Nutrinia Short Bowel Syndrome Product Overview
Table 63. Nutrinia Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Nutrinia Business Overview
Table 65. Nutrinia Recent Developments
Table 66. GlyPharma Therapeutics Short Bowel Syndrome Basic Information
Table 67. GlyPharma Therapeutics Short Bowel Syndrome Product Overview
Table 68. GlyPharma Therapeutics Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. GlyPharma Therapeutics Business Overview
Table 70. GlyPharma Therapeutics Recent Developments
Table 71. OxThera Short Bowel Syndrome Basic Information
Table 72. OxThera Short Bowel Syndrome Product Overview
Table 73. OxThera Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. OxThera Business Overview
Table 75. OxThera Recent Developments
Table 76. Ardelyx Short Bowel Syndrome Basic Information
Table 77. Ardelyx Short Bowel Syndrome Product Overview
Table 78. Ardelyx Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Ardelyx Business Overview
Table 80. Ardelyx Recent Developments
Table 81. Sancilio and Company Short Bowel Syndrome Basic Information
Table 82. Sancilio and Company Short Bowel Syndrome Product Overview
Table 83. Sancilio and Company Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Sancilio and Company Business Overview
Table 85. Sancilio and Company Recent Developments
Table 86. Naia Pharmaceuticals Short Bowel Syndrome Basic Information
Table 87. Naia Pharmaceuticals Short Bowel Syndrome Product Overview
Table 88. Naia Pharmaceuticals Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Naia Pharmaceuticals Business Overview
Table 90. Naia Pharmaceuticals Recent Developments
Table 91. Zealand Pharma Short Bowel Syndrome Basic Information
Table 92. Zealand Pharma Short Bowel Syndrome Product Overview
Table 93. Zealand Pharma Short Bowel Syndrome Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Zealand Pharma Business Overview
Table 95. Zealand Pharma Recent Developments
Table 96. Global Short Bowel Syndrome Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Short Bowel Syndrome Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Short Bowel Syndrome Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Short Bowel Syndrome Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Short Bowel Syndrome Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Short Bowel Syndrome Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Short Bowel Syndrome Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Short Bowel Syndrome Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Short Bowel Syndrome Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Short Bowel Syndrome Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Short Bowel Syndrome Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Short Bowel Syndrome Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Short Bowel Syndrome Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Short Bowel Syndrome Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Short Bowel Syndrome Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Short Bowel Syndrome Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Short Bowel Syndrome Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Short Bowel Syndrome
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Short Bowel Syndrome Market Size (M USD), 2019-2030
Figure 5. Global Short Bowel Syndrome Market Size (M USD) (2019-2030)
Figure 6. Global Short Bowel Syndrome Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Short Bowel Syndrome Market Size by Country (M USD)
Figure 11. Short Bowel Syndrome Sales Share by Manufacturers in 2023
Figure 12. Global Short Bowel Syndrome Revenue Share by Manufacturers in 2023
Figure 13. Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Short Bowel Syndrome Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Short Bowel Syndrome Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Short Bowel Syndrome Market Share by Type
Figure 18. Sales Market Share of Short Bowel Syndrome by Type (2019-2024)
Figure 19. Sales Market Share of Short Bowel Syndrome by Type in 2023
Figure 20. Market Size Share of Short Bowel Syndrome by Type (2019-2024)
Figure 21. Market Size Market Share of Short Bowel Syndrome by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Short Bowel Syndrome Market Share by Application
Figure 24. Global Short Bowel Syndrome Sales Market Share by Application (2019-2024)
Figure 25. Global Short Bowel Syndrome Sales Market Share by Application in 2023
Figure 26. Global Short Bowel Syndrome Market Share by Application (2019-2024)
Figure 27. Global Short Bowel Syndrome Market Share by Application in 2023
Figure 28. Global Short Bowel Syndrome Sales Growth Rate by Application (2019-2024)
Figure 29. Global Short Bowel Syndrome Sales Market Share by Region (2019-2024)
Figure 30. North America Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Short Bowel Syndrome Sales Market Share by Country in 2023
Figure 32. U.S. Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Short Bowel Syndrome Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Short Bowel Syndrome Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Short Bowel Syndrome Sales Market Share by Country in 2023
Figure 37. Germany Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Short Bowel Syndrome Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Short Bowel Syndrome Sales Market Share by Region in 2023
Figure 44. China Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Short Bowel Syndrome Sales and Growth Rate (K Units)
Figure 50. South America Short Bowel Syndrome Sales Market Share by Country in 2023
Figure 51. Brazil Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Short Bowel Syndrome Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Short Bowel Syndrome Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Short Bowel Syndrome Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Short Bowel Syndrome Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Short Bowel Syndrome Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Short Bowel Syndrome Market Share Forecast by Type (2025-2030)
Figure 65. Global Short Bowel Syndrome Sales Forecast by Application (2025-2030)
Figure 66. Global Short Bowel Syndrome Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Short Bowel Syndrome
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Short Bowel Syndrome Market Size (M USD), 2019-2030
Figure 5. Global Short Bowel Syndrome Market Size (M USD) (2019-2030)
Figure 6. Global Short Bowel Syndrome Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Short Bowel Syndrome Market Size by Country (M USD)
Figure 11. Short Bowel Syndrome Sales Share by Manufacturers in 2023
Figure 12. Global Short Bowel Syndrome Revenue Share by Manufacturers in 2023
Figure 13. Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Short Bowel Syndrome Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Short Bowel Syndrome Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Short Bowel Syndrome Market Share by Type
Figure 18. Sales Market Share of Short Bowel Syndrome by Type (2019-2024)
Figure 19. Sales Market Share of Short Bowel Syndrome by Type in 2023
Figure 20. Market Size Share of Short Bowel Syndrome by Type (2019-2024)
Figure 21. Market Size Market Share of Short Bowel Syndrome by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Short Bowel Syndrome Market Share by Application
Figure 24. Global Short Bowel Syndrome Sales Market Share by Application (2019-2024)
Figure 25. Global Short Bowel Syndrome Sales Market Share by Application in 2023
Figure 26. Global Short Bowel Syndrome Market Share by Application (2019-2024)
Figure 27. Global Short Bowel Syndrome Market Share by Application in 2023
Figure 28. Global Short Bowel Syndrome Sales Growth Rate by Application (2019-2024)
Figure 29. Global Short Bowel Syndrome Sales Market Share by Region (2019-2024)
Figure 30. North America Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Short Bowel Syndrome Sales Market Share by Country in 2023
Figure 32. U.S. Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Short Bowel Syndrome Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Short Bowel Syndrome Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Short Bowel Syndrome Sales Market Share by Country in 2023
Figure 37. Germany Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Short Bowel Syndrome Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Short Bowel Syndrome Sales Market Share by Region in 2023
Figure 44. China Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Short Bowel Syndrome Sales and Growth Rate (K Units)
Figure 50. South America Short Bowel Syndrome Sales Market Share by Country in 2023
Figure 51. Brazil Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Short Bowel Syndrome Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Short Bowel Syndrome Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Short Bowel Syndrome Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Short Bowel Syndrome Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Short Bowel Syndrome Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Short Bowel Syndrome Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Short Bowel Syndrome Market Share Forecast by Type (2025-2030)
Figure 65. Global Short Bowel Syndrome Sales Forecast by Application (2025-2030)
Figure 66. Global Short Bowel Syndrome Market Share Forecast by Application (2025-2030)
